Categories
Tags
Authors: Isidori AM, Giannetta E, Pofi R, Venneri MA, Gianfrilli D, Campolo F PMID: 32526061 PMCID: PMC7307129 DOI: 10.1111/andr.12837 Abstract Background: A pandemic outbreak of COVID-19 has been sweeping the world since December. It begins as a respiratory infection that, mainly in men with diabetes or renal impairment, evolves into a systemic disease, with SARDS, [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19
Authors: Zeh HJ, Bahary N, Boone BA, Singh AD, Normolle Dp, Hogg ME PMID: 32156749 PMCID: PMC8086597 DOI: 10.1158/1078-0432.CCR-19-4042 Abstract Purpose: We hypothesized that autophagy inhibition would increase response to chemotherapy in the preoperative setting for patients with pancreatic adenocarcinoma. We performed a randomized controlled trial to assess the autophagy inhibitor hydroxychloroquine in combination with [...]
Categories: I-RECOVER Post-Vaccine
Tags: autophagy, Cancer, Hydroxychloroquine
Authors: Calis Z, Mogulkoc R, Baltaci AK. PMID: 31288717 DOI: 10.2174/1389557519666190617150051 Abstract The inflammatory process in the human body is a physiological response involving many cellular types and mediators. It results in scar formation to separate the damaged area from the surrounding healthy tissue. Because of increased blood-brain barrier permeability following inflammation, leukocytes infiltrate the [...]
Categories: I-CARE Early Covid, I-CARE Flu and RSV, I-PREVENT, I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: flavonoids, Neuroinflammation
Authors: Mario L, Roberto M, Marta L, Teresa CM, Laura M PMID: 32939238 PMCID: PMC7478270 doi: 10.4103/ijpvm.IJPVM_258_20 Abstract Backgound: Bacterial or viral infections often cause acute and severe systemic inflammation, which affects the lungs lipopolysaccharide (LPS), a pathogenic component of the membrane of gram-negative bacteria, stimulates active innate immune cells, monocytes, macrophages to produce inducible [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19, Sildenafil
Authors: Reiter RJ, Sharma R, Ma Q, Liu C, Manucha W, Abreu-Gonzalez P DOI: https://doi.org/10.32794/mr11250068 Abstract COVID-19 has infected hundreds of thousands and killed tens of thousands of people worldwide and it continues to ravage societies as well as fiscal and economic stability of several countries. Currently, several drugs that were designed for other [...]
Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: COVID-19, Glucose Metabolism, Melatonin
Authors: Wang J, Wang Y, Zhou H, Gu W, Wang X, Yang J PMID: 32317585 DOI: 10.1097/MEG.0000000000001737 Abstract Objective: The aim of the study was to investigate the clinical efficacy and safety of ketotifen for the treatment of irritable bowel syndrome with diarrhea (IBS-D). Methods: A total of 108 enrolled IBS-D patients were randomly divided [...]
Categories: I-RECOVER Post-Vaccine
Tags: Ketotifen
Authors: Unal G, Turan B, Balcioglu YH PMID: 32498007 PMCID: PMC7255327 DOI: 10.1016/j.mehy.2020.109891 Abstract Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) which leads to COVID-19, was first seen in Wuhan province of China in December 2019 and spread globally in a short time. COVID-19 was announced as a pandemic by WHO on March 11th, 2020 and approximately [...]
Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine
Tags: COVID-19, Valproic Acid
Authors: Tripathy S, Dassarma B, Roy S, Chabalala H, Matsabisa MG PMID: 32450198 PMCID: PMC7243790 DOI: 10.1016/j.ijantimicag.2020.106028 Abstract Chloroquine (CQ) and its analogue hydroxychloroquine (HCQ) have long been used worldwide as frontline drugs for the treatment and prophylaxis of human malaria. Since the first reported cases in Wuhan, China, in late December 2019, humans have [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19, Hydroxychloroquine, SARS-CoV-2
Authors: De Maio A, Hightower LE PMID: 32424591 PMCID: PMC7232923 DOI: 10.1007/s12192-020-01121-0 Abstract The current coronavirus disease 2019 (COVID-19) pandemic has become an unprecedented challenge for the healthcare system worldwide, with an overwhelming number of patients requiring clinical attention and an unacceptably high mortality rate within critical care facilities. COVID-19 is caused by a novel [...]
Categories: I-RECOVER Post-Vaccine
Authors: Wahedi HM, Ahmad S, Abbasi SW PMID: 32345140 DOI: 10.1080/07391102.2020.1762743 Abstract The pandemic coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents a great threat to public health. Currently, no potent medicine is available to treat COVID-19. Quest for new drugs especially from natural plant sources is an area of [...]
Categories: I-RECOVER Post-Vaccine
Tags: COVID-19